Page 3 - Pharmaceutical Firms

Drug maker Lupin reports consolidated net loss of Rs 2,098 cr in Q2

Drug maker Lupin on Thursday reported a consolidated net loss

Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages

Lupin launches generic Duexis tablets in US to treat rheumatoid arthritis

Drug firm Lupin on Wednesday said it has launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and osteoarthritis in the US market.

Back to old normal: Pharma industry returns to pre-pandemic growth level

In this first instalment of a four-part series on how some of the defining numbers in key sectors are springing back to the pre-pandemic level, Sohini Das looks at India's pharmaceutical sector

Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine

Pharma major Morepen Laboratories has started the production of the test batch of the Russian Sputnik V coronavirus vaccine in Himachal Pradesh, the company has said

Best of BS Opinion: A jab at veracity, Jet Airways revival, and more

Here are the best of Business Standard's opinion pieces for Thursday

Honeywell launches authentication tech to prevent counterfeit pharma drugs

Honeywell on Monday announced digital authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products

Indian envoy holds meetings with CEOs of top US companies on Covid crisis

The Indian envoy in the US is having an intense engagement with the CEOs of top American companies to help India get the necessary medical equipment and drugs to combat the pandemic

Venus Remedies posts 61% increase in FY21 annual sales at Rs 548 crore

Pharmaceutical firm Venus Remedies has recorded a 61% increase in annual sales at Rs 548.12 crore in the financial year 2020-21

Seeking clarity, guidance from govt for Covid vaccine import: Cipla

Pharma major Cipla on Tuesday said it is seeking clarity and guidance from the government on the possible roadmap to import vaccine, while stressing that it has been at the forefront of Covid-19 care

Indore-based Modern Lab to manufacture Black Fungus drug Amphotericin B

The Madhya Pradesh government has given permission to the Indore-based Modern Laboratories to manufacture Amphotericin B drug used in the treatment of Black Fungus, White Fungus, and Yellow Fungus

Divi's Labs Q4 net profit jumps 29% at Rs 502 crore on robust sales

Drug firm Divi's Laboratories on Saturday reported a 29.30 percent rise in its consolidated net profit to Rs 502.02 crore for the quarter ended March 31, 2021, on account of robust sales

Zydus introduces scratch code in critical drug packs to fight counterfeit

Drug firm Zydus Cadila on Friday said it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited

Drugmaker Zydus Cadila's fourth quarter net profit up 73% at Rs 679 crore

Total income from operations of Rs 3,847 crore was up by 3 per cent from Rs 3,752 crore in Q4 FY20.

Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

Covid second wave pushes India's pharma industry growth to 59% in April

The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector

Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore

Biocon has reported 86.29% jump in consolidated profit to Rs 296.4 crore for the quarter ended March 31, 2021

Covid-19: Govt waives import duty on Remdesivir injection, raw materials

Given the shortage of supplies, the Union government last week banned the export of Remdesivir

Clinically tried and tested: Bharat Biotech boss Ella wins Covaxin fight

Covaxin was India's first indigenously developed vaccine to be approved, controversially under "clinical trial mode" in the first week of January

PE firm Advent International acquires 51% stake in ZCL Chemicals

ZCL is one of the fastest-growing manufacturers of specialty active pharmaceutical ingredients (APIs) and advanced intermediates